Ningbo Menovo Pharmaceutical Co Ltd
603538
Company Profile
Business description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Contact
No.999,Yangfan Road
Room 1406, No.1
High-tech Zone
Ningbo315040
CHNT: +86 57487357091
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,472
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
stocks
Is there a long-term buying opportunity in luxury stocks?
Our analysts think the recent wobble in revenue growth is cyclical, not structural.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,102.10 | 11.70 | 0.13% |
| CAC 40 | 7,830.11 | 23.48 | -0.30% |
| DAX 40 | 23,527.05 | 112.36 | -0.48% |
| Dow JONES (US) | 46,381.54 | 66.27 | 0.14% |
| FTSE 100 | 9,226.68 | 10.01 | 0.11% |
| HKSE | 26,344.14 | 200.96 | -0.76% |
| NASDAQ | 22,788.98 | 157.50 | 0.70% |
| Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
| NZX 50 Index | 13,141.54 | 90.12 | -0.68% |
| S&P 500 | 6,693.75 | 29.39 | 0.44% |
| S&P/ASX 200 | 8,810.90 | 11.40 | 0.13% |
| SSE Composite Index | 3,828.58 | 8.49 | 0.22% |